Working to Eradicate Gynecologic Cancers

Scientific Plenary V: Late Breaking Abstracts

Monday, March 24, 2014: 8:15 AM-9:50 AM
Ballroom B/C (Tampa Convention Center)
Description: Late breaking abstracts representative of cutting edge research will be presented
Moderator:  Seiko Diane Yamada, MD, University of Chicago, Chicago, IL
8:15 AM
Moderator Introductions in Scientific Plenary: Scientific Plenary V: Late Breaking Abstracts
S. D. Yamada
University of Chicago, Chicago, IL
 
8:20 AM
Announcement of International Travel Scholars
L. T. Chuang
Icahn School of Medicine at Mount Sinai, New York, NY
 
8:22 AM
Announcement of the Wilma Williams Education and Clinical Research Award for Endometrial Cancer
 
8:24 AM
Announcement of the Improving Outcomes in Gynecologic Oncology Patients Research Award (From the Gynecologic Oncology Group)
 

 
8:27 AM
Late Breaking Abstract 1
A Randomized Phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group tr
D. S. McMeekin1, V. L. Filiaci2, C. Aghajanian3, J. Cho4, J. W. Kim5, P. A. DiSilvestro6, D. M. O'Malley7, T. J. Rutherford8, L. Van Le9 and M. E. Randall10
1The University of Oklahoma, Oklahoma City, OK, 2Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, 3Memorial Sloan Kettering Cancer Center, New York, NY, 4University Oh Hawaii, hawaii, HI, 5KGOG, Seoul, South Korea, 6Women & Infants Hospital, Brown University, Providence, RI, 7The Ohio State University, Columbus, OH, 8Yale University School of Medicine, New Haven, CT, 9University Of North Carolina, Chapel Hill, Chapel Hill, NC, 10University of Kentucky Medical Center, Lexington, KY
 

 
8:38 AM
Late Breaking Abstract 2
A phase II study to determine the response to second curettage as initial management for persistent "low-risk" non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study
R. J. Osborne1, V. L. Filiaci2, R. S. Mannel3, S. A. Davidson4, J. S. Hoffman5, N. M. Spirtos6, J. K. Chan7, J. C. Schink8, J. Tidy9 and D. S. Miller10
1University of Toronto, Toronto, ON, Canada, 2Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, 3University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4University of Colorado Denver, Aurora, CO, 5New Britain General Hospital, Plainville, CT, 6Women's Cancer Center, Las Vegas, NV, 7UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA, 8Northwestern University Feinberg School of Medicine, Chicago, IL, 9Royal Hallamshire Hospital, Sheffield, United Kingdom, 10The University of Texas Southwestern Medical Center, Dallas, TX
 

 
8:49 AM
Late Breaking Abstract 3
Geriatric assessment and tolerance to chemotherapy in elderly women with ovarian, primary peritoneal or fallopian tube cancer: a Gynecologic Oncology Group study
V. E. Von Gruenigen1, H. Huang2, W. Tew3, A. H. Hurria4, H. Lankes2, P. A. DiSilvestro5, R. S. Mannel6, J. H. Beumer7, A. Heugel8 and T. J. Herzog9
1Northeast Ohio Medical University (NEOMED), Rootstown, OH, 2Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, 3Memorial Sloan Kettering Cancer Center, New york City, NY, 4City of Hope, Duarte, CA, 5Women & Infants Hospital, Brown University, Providence, RI, 6University of Oklahoma Health Sciences Center, Oklahoma City, OK, 7UNiversity of Pittsburgh Cancer Institute, Pittsburgh, PA, 8University Hospitals Ireland Cancer Center, Cleveland, OH, 9Columbia University College of Physicians and Surgeons, New York, NY
 

 
9:00 AM
Late Breaking Abstract 4
SMARCA4 Mutations in Small Cell Carcinoma of the Ovary
J. J. Mueller1, P. Jelinic1, N. Olvera2, F. Dao1, R. A. Soslow1, M. F. Berger2 and D. A. Levine1
1Memorial Sloan Kettering Cancer Center, New York, NY, 2Memorial Sloan-Kettering Cancer Center, New York, NY
 

 
9:11 AM
Late Breaking Abstract 5
Risk of developing uterine corpus cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations
C. A. Shu1, M. Pike1, A. R. Jotwani1, R. A. Soslow2, D. A. Levine2, J. Konner1, C. Aghajanian2, K. Offit1, R. R. Barakat2 and N. D. Kauff2
1Memorial Sloan-Kettering Cancer Center, New York, NY, 2Memorial Sloan Kettering Cancer Center, New York, NY
 
9:21 AM
Panel Discussion
 
9:30 AM
106 - Scientific Plenary
Burnout is associated with decreased career satisfaction and psychosocial distress among members of the Society of Gynecologic Oncology (SGO)
K. Rath1, L. Huffman2, K. Carpenter2 and J. M. Fowler2
1Ohio Health Gynecologic Cancer Surgeons, Columbus, OH, 2The Ohio State University, Columbus, OH
 
9:40 AM
Lecturette
J. M. Austin Jr.
University of Alabama at Birmingham, Birmingham, AL
 
See more of: Scientific Plenary
<< Previous Course | Next Course >>